Clinical trials
Recruiting Phase 2 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 14 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 20 |
| The University of Hong Kong | 7 |
| Hong Kong Children's Hospital | 3 |
| Bristol-Myers Squibb | 2 |
| Christopher Kai Shun Leung | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Pfizer | 2 |
| Taiho Oncology, Inc. | 2 |
| ADARx Pharmaceuticals, Inc. | 1 |
| Amplexd Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Lung Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Carcinoma | 2 |
| Fallopian Tube Neoplasms | 2 |
| Glaucoma | 2 |
| Lung Diseases | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Alzheimer Disease | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.